Codes, standards and reports

The GSK Code sets out the commitments GSK and our people make to get ahead together – so we can deliver on our ambition in the right way, bring our culture to life and make GSK an exciting and inspiring place to work.

The Anti-Bribery and Corruption (ABAC) Programme is part of GSK’s response to the threat and risk of bribery and corruption. The programme includes an ABAC Policy, which has been designed to help our people and external parties understand bribery and corruption risk, and their responsibilities to actively combat it.

The Financial Conflicts of Interest policy is a National Institutes of Health specific supplement to GSK’s Conflict of Interest and Anti-Bribery and Corruption policies to incorporate specific US federal regulatory requirements intended to promote and encourage transparency and avoid inappropriate use of US Public Health Service funding. This policy helps ensure that government funded research is conducted without bias and with the highest scientific and ethical standards by principle investigators.

This policy provides the principles for promotional and non-promotional external interactions so that these interactions:

• support external understanding and appropriate use of GSK products for the benefit of individual patients and populations
• are transparent, appropriate, ethical, and comply with relevant laws, regulations, and industry codes

This version of our internal policy has personal information and internal document references redacted.

Our annual Modern Slavery Act statement, as required by the Modern Slavery Act 2015 (“the Act”), provides details on the controls we have adopted to ensure that modern slavery and human trafficking do not take place in our supply chain or in any part of our business. The statement covers our financial year which runs from 1 January to 31 December.

As detailed in our Code of Conduct, we do not tolerate harassment, unwelcome, unreasonable or offensive behaviour or discrimination of any kind. Our Equal and Inclusive Treatment policy is designed to help our employees and complementary workers understand their role in ensuring GSK is a company where all employees are treated equally.

Our human resources and research and development activities involve the processing of “personal information”, including the transfer of that personal information internationally.  We have adopted Binding Corporate Rules (BCRs) to enable us to make international transfers of personal information within our group of companies in compliance with data protection laws of the European Union, in particular the General Data Protection Regulation (Regulation 2016/679) (GDPR).

GSK is committed to protecting people and the environment, moving towards our sustainability ambitions and promoting wellbeing and the safety of our people.  Our Environment, Health and Safety policy sets out our approach to managing EHS risks and creating opportunities across our organisation to fulfil our EHS protection commitments, both internally and externally.

Occupational Health and Safety is part of EHS at GSK and information on our management systems can be found in our Occupational Health and Safety report.

Our company-wide risk management and internal control policy defines the requirements, roles and responsibilities for the management and governance of risks and internal controls and highlights expected risk management behaviours aligned to The Code. Implementation of our risk management and internal control framework and policy ensures our operations are conducted in a controlled, efficient and sustainable manner by outlining the critical elements in identifying, assessing, and managing risks that could impact operations, reputation, financial standing and license to operate. Our risk management and internal control framework provides the ability for the Board to evaluate and oversee how the company manages principal and emerging risks in line with our strategy and long-term priorities.